USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Aurigene Discovery Technologies Limited

USPTO PatentsView assignee record - 42 granted patents across 8 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Aurigene ranks #7,663 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 8 technology areas.

#7,663
of 49,997 US assignees by volume
Top 26%
by Innovation Score (44.1/100)
24.1
avg claims per patent
+21%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7663 · Foreign Corporation #7,663 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 42 grants
  • UPPER-Q #7,663/49,997
  • PHOTO-FINISH Amtech Systems
  • CPC-NARROW C07D · 8 areas
  • INNOV-PAR 44.1/100
  • CLAIMS-DENSE 24.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +21% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Amtech Systems, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aurigene’s 44.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Aurigene

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Aurigene's Innovation Score is 44.1/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Aurigene?

Each dot is one of Aurigene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aurigene’s own 24.1 claims/patent is ABOVE the 18.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Aurigene vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 41.942.042.04242.042.042.1 051015202530 Granted patents (volume) Avg claims / patent Amtech Systems, LLC - 42, 14.95Amtech SystemsArity International Limited - 42, 18.79Arity Internation…Armaments Research Company, Inc. - 42, 19.26Armaments ResearchAttochron, LLC - 42, 18.95AttochronBanma Zhixing Network (HONGKONG) Co., Limited - 42, 19.9Banma Zhixing Net…Beijing Superstring Academy OF Memory Technology - 42, 15.02Beijing Superstri…Blackmore Sensors & Analytics, LLC. - 42, 19.07Blackmore Sensors…Bond Manufacturing Co., Inc. - 42, 2.64Bond ManufacturingAurigene Discovery Technologies Limited - 42, 24.07Aurigene Discovery
Aurigene vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aurigene's grants concentrate

Aurigene Discovery Technologies Limited is a focused PatentsView assignee: 8 CPC subclasses with 83.3% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2022 (9 grants) versus a trough of 1 in 2019. By volume, Aurigene sits between Amtech Systems, LLC and Bond Manufacturing Co., Inc..

Aurigene's three-year grant acceleration

Aurigene Discovery Technologies Limited shows 12 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Aurigene's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Aurigene holds 42 patents at rank #7,663, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Aurigene

By rank, the assignees closest to #7,663 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Aurigene's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Aurigene, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Aurigene ranks #241 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Aurigene's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 201520162017201820192020202120222023 3
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Aurigene Discovery Technologies Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 11.9%
2016 3 7.1%
2017 4 9.5%
2018 6 14.3%
2019 1 2.4%
2020 4 9.5%
2021 7 16.7%
2022 9 21.4%
2023 3 7.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Aurigene Discovery Technologies Limited's patent record in context - here's where to go next.

  • Aurigene Discovery Technologies Limited's lead technology class is C07D (Heterocyclic Compounds), 83.3% of its portfolio - see every assignee active in that class. Explore C07D
  • Ranked #7,663 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Aurigene Discovery Technologies Limited against Amtech Systems, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 44.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.